12 Aug 2013
Pancreatic cancer focus of applications by NZ drug firm
Patients with a particularly deadly cancer may one day benefit from an unusual initiative by a fledgling New Zealand-owned drug company.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
